The epidemiological literature reports inconsistent associations between consumption or circulating concentrations of micro-nutrients and breast cancer risk. We investigated associations between genetically determined concentrations of 11 micro-nutrients (beta-carotene, calcium, copper, folate, iron, magnesium, phosphorus, selenium, vitamin B6, vitamin B12 and zinc) and breast cancer risk using Mendelian randomization (MR).
Introduction
Breast cancer is the most common cancer in women with an estimated 2.1 million new cases and over half a million deaths worldwide in 2018 [1] . Breast cancer is a heterogeneous disease and its epidemiology varies with menopausal and tumour receptor status at time of diagnosis. Established risk factors for post-menopausal breast cancer include adiposity, endogenous concentrations of estrogens and androgens and reproductive factors such as early menarche, late menopause, late age at first pregnancy and hormone replacement therapy [2] . The role of nutrition in breast cancer development is unclear. The World Cancer Research Fund (WCRF) has recently systematically reviewed all literature on the associations of dietary and nutritional factors with breast cancer [3] . The WCRF report concluded that the evidence was strong only for a positive association between alcohol consumption and risk of pre-and post-menopausal breast cancer, whereas limited but suggestive evidence was found for inverse associations between consumption of non-starchy vegetables and foods containing carotenoids and calcium with risk of pre-and postmenopausal breast cancer [3] . The literature on circulating concentrations of minerals and vitamins with risk of breast cancer is generally not extensive with perhaps the exceptions of carotenoids and vitamin D [3] .
Most of the evidence regarding the nutritional epidemiology of breast cancer comes from observational studies that often rely on food frequency questionnaires (FFQ) to measure the consumption of foods and nutrients. This approach is prone to measurement error, because it is based on participants' self-reports that might be inaccurate leading to biased results [4] . Furthermore, individuals who follow different dietary patterns might also differ in other aspects, which are not always adequately controlled for in statistical confounder adjustments [5, 6] . Evidence from clinical 6 trials is also lacking, as there are not many adequately powered trials that have evaluated the effect of micro-nutrients and cancer risk [7] [8] [9] [10] .
A Mendelian randomization (MR) approach can be used to assess the existence of a potential causal association between a risk factor and disease. MR attempts to emulate a randomized controlled trial (RCT) within an observational setting using genetic variants as instrumental variables for the risk factor of interest [11] . As genotype is allocated randomly at conception, genetic variants are not influenced by potential confounding factors, such as environmental exposures, and cannot be altered by disease occurrence.
The aim of the current study was to investigate potential causal associations of genetically determined circulating concentrations of minerals and vitamins with risk of overall breast cancer and cancer by estrogen receptor status (ER +ve and ER -ve ) using MR methodology.
Methods

Data on the genetic epidemiology of circulating nutrients concentrations
The Genome-Wide Association Studies (GWAS) catalog (https://www.ebi.ac.uk/gwas) and Pubmed (https://www.ncbi.nlm.nih.gov/pubmed) were searched (last checked on September 2017) for published GWASs on circulating concentrations of minerals and vitamins that were conducted in populations of European ancestry. The initial list included 20 nutrients: beta-carotene, calcium, copper, folate, iron, magnesium, phosphorus, potassium, retinol, selenium, sodium, vitamins B1, B2, B6, B12, C, D, E, and K, and zinc. Vitamin D was excluded because recent MR studies have investigated the role of circulating vitamin D concentrations 7 and risk of breast cancer [12, 13] . Potassium, sodium, vitamins B1, B2, C and K were also excluded because either no genome-wide significant results have been reported [14, 15] or no GWAS has been conducted. Two further GWAS, those for circulating vitamin E and retinol, were excluded because they adjusted for body mass index (BMI), which may bias MR estimates [16] [17] [18] [19] . Published GWAS for 11 nutrients were finally retrieved, namely beta-carotene, calcium, copper, folate, iron, magnesium, phosphorus, selenium, vitamins B6 and B12 and, zinc [14, [20] [21] [22] [23] [24] [25] [26] [27] . Single nucleotide polymorphisms (SNPs) that independently affected the concentrations of these nutrients at a genome wide significance level ‫(‬ [30] . Out of the 47 SNPs, rs778805, that was associated with vitamin B12, was significantly associated with risk of overall breast cancer, and rs4072037, that was associated with magnesium, was significantly associated with both overall and ER +ve breast cancer ( Supplementary Table S1 ).
Statistical power
Power calculations were performed using an online tool available at http://cnsgenomics.com/shiny/mRnd/ [31] . The statistical power to capture an OR of 1.10 per a standard deviation (SD) change in the circulating concentrations of the nutrients, given a sample size of 228,951 participants, type 1 error of 5% and a proportion of cases equal to 0.54, ranged from 0.55 for calcium to 1 for copper, vitamin B12, and, zinc and the statistical power was between 0.80 and 1 for seven (i.e., beta -carotene, copper, iron, magnesium, selenium, vitamin B12, and zinc) of the 11 instruments tested ( Supplementary Table S2 ).
Mendelian Randomization analysis
Two-sample MR using summary association data was performed. In the case of beta-carotene, where only one SNP was available, the effect estimate was calculated as the ratio of the SNP-outcome over the SNP-nutrient association [32] , whereas the fixed -effect inverse variance weighted (IVW) method was implemented when the instruments consisted of multiple SNPs, and this analysis can be thought as a meta-analysis of single SNP effects [32, 33] . The beta estimates from the regressions for circulating concentrations for beta-carotene, copper, selenium, vitamin B6, and zinc were transformed from the logarithmic scale that were originally reported in the published GWAS to the natural scale using a published formula [34] .
All reported associations correspond to OR for risk of breast cancer per SD change in the circulating concentrations of the nutrients.
To be valid instruments for the MR analysis, the selected genetic variants must meet the following criteria: i) be associated with the circulating concentrations of the nutrients, ii) be independent of any potential confounding variable of the nutrientbreast cancer association, and iii) affect breast cancer only through the nutrient being instrumented and not via any other pathway [35] . The strength of each instrument was measured using the F statistic calculated by the formula:
where R 2 is the proportion of the explained variance of the nutrient by the genetic instrument and N the sample size of the GWAS for the SNP-nutrient association [36] .
The R 2 was calculated using an already published formula [37] .
Sensitivity analyses
The second and third MR assumptions was examined by performing the following statistical analyses: Cochran's Q [38] , random effects IVW MR analysis [39] , MR-Egger regression [40] , weighted median [35] , weighted mode approach (WMA) [41] , the MR pleiotropy residual sum and outlier test (MR-PRESSO) [42] , and a leave one SNP out analysis. More details are provided in the supplementary methods. We further evaluated whether the selected genetic instruments were associated with secondary phenotypes in Phenoscanner (http://www.phenoscanner.medschl.cam.ac.uk/) and GWAS catalog (last checked May 2018) [43, 44] . All analyses were implemented in the statistical software R version 3.4.3 using the package MendelianRandomization [45] . There was little evidence that any of the other nutrients were associated with risk of breast cancer or its subtypes (Figure 1 ).
Results
Mendelian randomization estimates
Evaluation of Mendelian randomization assumptions
The F-statistic was larger than 10 for all the included variants implying absence of weak instruments (minimum value=16, maximum value=420)
( Supplementary Table S1 ).
Cochran's Q test was not significant for all analyses, except for vitamin B12 and overall breast cancer risk (Cochran's Q P= 0.02) however, no change was observed in the results after performing the random effects IVW MR ( Supplementary   Table 3 ). Additionally, some indication of horizontal pleiotropy was found in the analysis of calcium and overall breast cancer risk based on the MR-Egger test (intercept P= 0.02) ( Supplementary Table S3 ). Table S4 ). A positive association was observed between genetically determined vitamin B12 concentrations and overall breast cancer risk based on the weighted median approach (OR: 1.08, 95% CI: 1.01 to 1.15). There was little evidence that any of the other nutrients were associated with risk of breast cancer in sensitivity analyses ( Supplementary Table S4 ). Finally, the MR-PRESSO analysis did not reveal any outlying SNPs, which was also evident when we estimated and plotted the MR results for all nutrients by each separate SNP (Supplementary Figures S1-S10).
When we iteratively excluded one SNP at a time from all genetic instruments to further probe into potential SNP outliers, the positive association between genetically determined magnesium concentrations and risk of overall and ER +ve breast cancer remained significant ( Supplementary Table S5 ). However, when rs4072037 was removed from the genetic instrument for magnesium concentrations, the associations for risk of overall (OR: 1.11, 95% CL: 1.02 to 1.21) and ER +ve breast cancer (OR: 1.09, 95% CL: 0.98 to 1.21) were slightly attenuated. There was little evidence that any of the other nutrients were associated with risk of breast cancer in the leave one out analysis with the exceptions described below. The inverse association observed in the IVW analysis between genetically determined phosphorus concentration and the risk of ER -ve breast cancer was not present after removal of rs1697421, rs947583 or rs297818. When rs1801725 was excluded from the genetic instrument of calcium concentrations, a protective effect was observed for overall (OR: 0.79, 95% CI: 0.68 to 0.91) and ER +ve breast cancer (OR: 0.82, 95% CL: 0.69 to 0.98).
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Several genome-wide significant associations of the genetic instruments with secondary traits were observed ( Supplementary Table S6 ). Some of these may be associated with breast cancer and are potential causes of horizontal pleiotropy, namely associations with diabetes, height, insulin resistance, C-reactive protein, glycosylated haemoglobin, and age at menarche. However, when the SNPs that were associated with the latter secondary phenotypes were excluded in the leave one out analysis, the observed associations of the genetic instruments with breast cancer did not change ( Supplementary Table S5 ).
Discussion
In interpretation of this finding is unclear, as breast density is a risk factor for breast cancer but it may also obscure detection of the disease [47] [48] [49] . The genetic instruments used in our analysis affect magnesium homeostasis and mechanistic studies suggest that increased concentrations of magnesium within breast cancer cells can lead to tumour progression through the regulation of enzymes involved in energy generation, and its presence is also needed for cell adhesion and cancer metastasis [50, 51] . Evidence from animal studies suggests that magnesium has a protective effect in the early phases of chemical carcinogenesis but promotes tumour growth [52] . There are no magnesium supplementation trials assessing relevant cancer outcomes. Our finding of a positive association between genetically determined magnesium concentrations and risk of breast cancer should be further evaluated in humans and animals using observational and interventional designs.
An inverse association was observed in our analysis between concentrations of phosphorus and ER -ve breast cancer. We found only one relevant cohort study involving 186,620 women, where 4,925 incident breast cancers developed during a mean follow-up of 13 years, reporting that a SD (0.17 mmol/L) increase in serum inorganic phosphate levels were inversely associated with total breast cancer risk (HR: 0.93, 95% CI: 0.90 to 0.96), but these estimates were not adjusted for potentially important confounders such as alcohol consumption and smoking status [53] . Our analysis did not confirm this association for total breast cancer (OR: 0.96, 95% CI: 0.88 to 1.04), but found an inverse association for ER -ve disease (OR: 0.84, 95% CI:
0.72 to 0.98). Studies have linked estrogen levels with negative regulation of circulating inorganic phosphate and high levels of estrogen are strongly positively associated with breast cancer [54] , but this mechanism is more relevant for ER +ve than ER -ve breast cancer. 1 4 Our primary analysis suggested an inverse association of calcium with breast cancer (OR: 0.91, 95% CI: 0.83 to 1.00). After the exclusion of rs1801725, this association stregthened for overall (OR: 0.79, 95% CI: 0.68 to 0.91) and ER +ve breast cancer (OR: 0.82, 95% CI: 0.69 to 0.98). Rs1801725 is located in the calcium-sensing receptor (CaSR) gene, which plays an important role in calcium metabolism and has been suggested to act as an oncogene for several cancers including breast [55].
However, results from GWAS indicate that rs1801725 is also associated with immunoglobulin E (IgE), bone mineral density, childhood obesity and adiponectin concentrations (all P<0.005) [56] [57] [58] [59] , which might reflect pleiotropic actions of this genetic variant. A recent meta-analysis of three prospective studies also reported an inverse association between serum calcium and breast cancer risk (RR: 0.80, 95% CI:
0.66 to 0.97, per 1 mmol/L increase in serum calcium) [60] . In addition, the third expert report from WCRF also reported an inverse association of dietary calcium with pre-menopausal (relative risk [RR] for 300mg/day increase of dietary calcium intake: 0.87, 95% CI: 0.76 to 0.99) and post-menopausal breast cancer (RR: 0.96, 95% CI:
0.94 to 0.99), but the evidence has been graded as limited-suggestive [3] . Possible mechanistic explanations could be that increased cytosolic levels of calcium might affect cell cycle processes and apoptosis through Ras and β -catenin pathways [61, 62] .
Our main analysis showed little evidence of an association between genetically determined circulating vitamin B12 concentrations with risk of breast cancer, although one of the vitamin B12 SNPs, rs778805, was associated with risk of overall breast cancer in the BCAC GWAS and the result of the weighted median analysis was significant for overall breast cancer. A recent meta-analysis of four observational studies concluded that there was no association between serum vitamin In conclusion, we conducted the first comprehensive two-sample MR study to investigate whether genetically determined concentrations of 11 micro-nutrients are associated with risk of breast cancer. An increased risk of overall and ER +ve disease was observed for genetically higher concentrations of magnesium that was robust to several different sensitivity analyses. Future studies are warranted to replicate this finding and to disentangle the potential underlying pathways. The authors have no conflicts of interest to disclose. 1 7 223175 and H2020 633784 and 634935). All studies and funders are listed in Michailidou et al (2017) .
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